Periodic Reporting for period 1 - FasNaGel (NOVEL THERAPEUTIC NANOHYDROGEL FOR ACUTE AND CHRONIC PAIN TREATMENT TARGETED TO THE NERVES FASCIA)

i+Med’s team has been working since 2014 in the development of FasNaGel: a new medical solution unique in Europe for the improvement of acute pain relief, which also prevents its chronification. FasNaGel is a new nanomedicinal product that consists of a biocompatible and...